Volume 7, Issue 2 e309
Advanced Review

Scarless wound healing: Transitioning from fetal research to regenerative healing

Alessandra L. Moore

Alessandra L. Moore

Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts

Department of Surgery, Stanford University School of Medicine, Stanford, California

Search for more papers by this author
Clement D. Marshall

Clement D. Marshall

Department of Surgery, Stanford University School of Medicine, Stanford, California

Search for more papers by this author
Leandra A. Barnes

Leandra A. Barnes

Department of Surgery, Stanford University School of Medicine, Stanford, California

Search for more papers by this author
Matthew P. Murphy

Matthew P. Murphy

Department of Surgery, Stanford University School of Medicine, Stanford, California

Search for more papers by this author
Ryan C. Ransom

Ryan C. Ransom

Department of Surgery, Stanford University School of Medicine, Stanford, California

Institute of Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California

Search for more papers by this author
Michael T. Longaker

Corresponding Author

Michael T. Longaker

Department of Surgery, Stanford University School of Medicine, Stanford, California

Institute of Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California

Correspondence

Michael T. Longaker, Department of Surgery, Stanford University School of Medicine, 291 Campus Drive, Stanford, CA 94305. Email: [email protected]

Search for more papers by this author
First published: 09 January 2018
Citations: 89
Funding information Stanford University Transplant and Tissue Engineering Center of Excellence; Stanford University Child Health Research Institute; American College of Surgeons Resident Research Scholarship; Stanford University Tissue and Transplant Engineering Center of Excellence Program Fellowship; Society of University Surgeons Resident Scholar Award

Abstract

Since the discovery of scarless fetal skin wound healing, research in the field has expanded significantly with the hopes of advancing the finding to adult human patients. There are several differences between fetal and adult skin that have been exploited to facilitate scarless healing in adults including growth factors, cytokines, and extracellular matrix substitutes. However, no one therapy, pathway, or cell subtype is sufficient to support scarless wound healing in adult skin. More recently, products that contain or mimic fetal and adult uninjured dermis were introduced to the wound healing market with promising clinical outcomes. Through our review of the major experimental targets of fetal wound healing, we hope to encourage research in areas that may have a significant clinical impact. Additionally, we will investigate therapies currently in clinical use and evaluate whether they represent a legitimate advance in regenerative medicine or a vulnerary agent. WIREs Dev Biol 2018, 7:e309. doi: 10.1002/wdev.309

This article is categorized under:

  • Adult Stem Cells, Tissue Renewal, and Regeneration > Regeneration
  • Plant Development > Cell Growth and Differentiation
  • Adult Stem Cells, Tissue Renewal, and Regeneration > Environmental Control of Stem Cells

Graphical Abstract

The discovery of fetal scarless skin wound healing is an important breakthrough whose investigation drives many aspects of regenerative medicine and stem cell research. Several features of fetal scarless wound healing are well studied, but the exact mechanism to recapitulate scarless wound healing in adult skin remains elusive (Reprinted with permission from Leavitt et al. (2016). Copyright 2016 Springer).